Tigem's gene-delivery technology allowed for an experimental therapy for congenital deafness to be successfully applied in Philadelphia.

Witness a monumental breakthrough in gene therapy led by Alberto Auricchio's visionary team at TIGEM Telethon Institute of Genetics and Medicine in Pozzuoli, Italy.
In this groundbreaking interview with Nature Italy, discover how their innovative gene-delivery technology has enabled an 11-year-old with congenital deafness to hear for the first time. 🌟

Auricchio's pioneering approach, addressing defects in the OTOF gene, marks a significant leap forward in medical science. Join us in celebrating this remarkable milestone and the transformative power of Auricchio's research!
Read the interview here